Healthcare Triangle to Acquire 51% of Cosmoinnovations for $23.5M, Entering Medtech
HCTI is trading near its 52-week low of $1.463 (6.7% above the low) on elevated volume (2.4× avg).
Summary
Healthcare Triangle signed a non-binding LOI to acquire a 51% stake in Cosmoinnovations for $23.5 million, gaining 27 granted patents and 61 pending, with a target of $50 million in revenue over three years. This marks a strategic pivot into proprietary medtech and consumer-health markets, diversifying beyond its recent financing-heavy trajectory. The deal follows a series of dilutive capital raises and shareholder approvals for massive share issuance, but the acquisition could provide a tangible growth catalyst if completed. The non-binding nature and lack of disclosed funding source introduce execution risk, especially given the company's $3.2 million market cap and ongoing cash burn. Investors will watch for a definitive agreement and financing details.
At the time of this announcement, HCTI was trading at $1.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $1.46 to $963.62. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.